OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical Treatment for Retinal Degenerative Pathologies: A Systematic Review
Lăcrămioara Samoilă, Oliviu Voştinaru, Elena Dinte, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8045-8045
Open Access | Times Cited: 12

Showing 12 citing articles:

Nanotechnology-based non-invasive strategies in ocular therapeutics: Approaches, limitations to clinical translation, and safety concerns
Pinal Chaudhari, Shaila A. Lewis, Vivek Ghate
Contact Lens and Anterior Eye (2025), pp. 102367-102367
Closed Access | Times Cited: 2

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 13

Formulation Advances in Posterior Segment Ocular Drug Delivery
Tumpa Sarkar, Niva Rani Gogoi, Bani Kumar Jana, et al.
Journal of Ocular Pharmacology and Therapeutics (2025)
Closed Access

Can Sustained Suppression of VEGF be Achieved by Topical Ocular Delivery?
David P. Bingaman, Tejaswini Appidi, Jahnavi Pejavar, et al.
American Journal of Ophthalmology (2025)
Closed Access

A look to the future: cyclodextrins and cyclodextrin-based drug delivery to the retina
Phatsawee Jansook, Hákon Hrafn Sigurðsson, Þorsteinn Loftsson
Expert Opinion on Drug Delivery (2025)
Closed Access

The Importance of Kinases in Retinal Degenerative Diseases
Paulo F. Santos, António Francisco Ambrósio, Hélène Léger
Kinases and Phosphatases (2024) Vol. 2, Iss. 1, pp. 93-109
Open Access | Times Cited: 2

An update on the latest strategies in retinal drug delivery
Ketan M. Ranch, Disha Chawnani, Harshilkumar Jani, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 5, pp. 695-712
Closed Access | Times Cited: 2

The impact of lutein-loaded poly(lactic-co-glycolic acid) nanoparticles following topical application: An in vitro and in vivo study
Renee T. Carter, Sean Swetledge, Sara Navarro, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306640-e0306640
Open Access | Times Cited: 2

PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells
Eduardo Anitua, Francisco Muruzábal, María de la Fuente, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11195-11195
Open Access | Times Cited: 3

Deletion of Transmembrane protein 184b leads to retina degeneration in mice
Guo Liu, Tiannan Liu, Junkai Tan, et al.
Cell Proliferation (2024)
Open Access

How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Martha Kim, Mi-Young Jung, Doyeon Lee, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1604-1604
Open Access

Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model
Alba Aragón-Navas, María Jesús Rodrigo, Inés Munuera, et al.
Drug Delivery and Translational Research (2024)
Open Access

Page 1

Scroll to top